91ÑÇÉ«´«Ã½

Earlier today, the 91ÑÇÉ«´«Ã½ announced that its three peer-reviewed journals will become, as of January, open access. You can read the announcement in full below. The society also created a page with frequently asked questions.

As elected, editorial and administrative leaders of the 91ÑÇÉ«´«Ã½, we are pleased to announce that the society’s three highly regarded journals — , and — will be fully open access beginning in January 2021.

The 91ÑÇÉ«´«Ã½ exists to meet the needs and respond to the demands of its members, and our members, in line with the broader scientific community, have called for immediate and free public access to research published in 91ÑÇÉ«´«Ã½ journals in order to reduce barriers to scientific knowledge and accelerate discoveries.

91ÑÇÉ«´«Ã½ journals have for years made accepted manuscripts immediately available for free as Papers in Press and have embargoed the final redacted versions of articles for subscribers for only a single year. In addition, authors have had the option to pay an additional fee for immediate open access of the final version of a paper or upload the accepted version for free to a public repository. As of January, the final versions of all articles will be immediately available to everyone, qualifying 91ÑÇÉ«´«Ã½ journals as “gold” open access. This is important because an increasing number of funders of biomedical research are requiring its grantees to publish in only “gold” journals.

Our decision-making process was careful and consultative. During our months-long deliberations, we had to balance what is best for science and scientists with what is sustainable for a nonprofit organization. Ultimately, we determined that the 91ÑÇÉ«´«Ã½ cannot achieve its goal of full open access alone, so we made the strategic decision to enter into an agreement with the commercial publisher , which has experience transitioning subscription journals to full open access and the requisite technical expertise and infrastructure.

We want to emphasize that this agreement will not change the peer-review process at any of our journals. JBC, MCP and JLR remain committed to rigorous, fast and fair review — by active scientists.

We are happy to report, also, that the agreement will smooth the submission process for authors and reduce the cost of open-access publishing — for both members and nonmembers alike. It also will make our journals easier to read on mobile devices, discoverable on the platform ScienceDirect and, generally speaking, more nimble technologically.

Transitioning from a subscription model to an open-access model is complicated, but we know this is the right decision for the 91ÑÇÉ«´«Ã½. Throughout our deliberations, we kept focused on our goal: to make the high-quality papers we publish immediately and permanently available for everyone to read, download, copy and distribute.

We will share more information on the transition in the months to come. In the meantime, we hope that you will reach out to us if you have any questions or concerns.

Sincerely,

Gerald Hart (President, 91ÑÇÉ«´«Ã½)
Joan Conaway (Treasurer, 91ÑÇÉ«´«Ã½)
Sandra Weller (Chair, 91ÑÇÉ«´«Ã½ Publications Committee)
Toni Antalis (President-elect, 91ÑÇÉ«´«Ã½)
Lila M. Gierasch (Editor-in-Chief, Journal of Biological Chemistry)
Alma Burlingame (Editor-in-Chief, Molecular & Cellular Proteomics)
Kerry-Anne Rye and Nicholas O. Davidson (Co-Editors, Journal of Lipid Research)
Barbara Gordon (Executive Director, 91ÑÇÉ«´«Ã½)
Nancy Rodnan (Senior Director, 91ÑÇÉ«´«Ã½ Publications)
Steve Miller (Deputy Executive Director and Chief Financial Officer, 91ÑÇÉ«´«Ã½)